↓ Skip to main content

The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study

Overview of attention for article published in Frontiers in Neurology, November 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study
Published in
Frontiers in Neurology, November 2018
DOI 10.3389/fneur.2018.01003
Pubmed ID
Authors

Mei-Tzu Wang, Cheng Ken Tsai, Shu-Hung Kuo, Wei-Chun Huang, Kun-Chang Lin, Wang-Ting Hung, Chin-Chang Cheng, Pei-Ling Tang, Cheng Chung Hung, Jin-Shiou Yang, Hsin-Li Liang, Guang-Yuan Mar, Chun-Peng Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 25%
Student > Master 3 19%
Student > Bachelor 1 6%
Other 1 6%
Professor > Associate Professor 1 6%
Other 0 0%
Unknown 6 38%
Readers by discipline Count As %
Medicine and Dentistry 7 44%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Neuroscience 1 6%
Psychology 1 6%
Unknown 6 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2018.
All research outputs
#17,998,207
of 23,116,036 outputs
Outputs from Frontiers in Neurology
#7,205
of 12,025 outputs
Outputs of similar age
#305,855
of 438,033 outputs
Outputs of similar age from Frontiers in Neurology
#178
of 319 outputs
Altmetric has tracked 23,116,036 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,025 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,033 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 319 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.